Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Famous.
Enzyme activity assays for protein kinases: Strategies to identify active substrates.
Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
Validity and Reliability of the Persian Version of the PERception de la Scle'rose En Plaques et de ses Pousse'es Questionnaire Evaluating Multiple Sclerosis-related Quality of Life.
Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study.
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.
Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgG.
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.
Chronic inflammatory demyelinating polyneuropathy with membranous nephropathy.
Development of the Oxford Participation and Activities Questionnaire: constructing an item pool.
Post-operative quadriplegia as the initial manifestation of tumefactive multiple sclerosis.
Spatial Analysis of Multiple Sclerosis Disease in Tehran Metropolitan Zone, Iran, 2001-2012.
[Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Exploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.
[Immunomodulatory effect of Huangqi glycoprotein on mice with experimental autoimmune encephalomyelitis].
Helping families thrive in the face of uncertainty: Strengths based approaches to working with families affected by progressive neurological illness.
New clinical insights into combined central and peripheral demyelination (CCPD).
Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis.
Automatic magnetic resonance spinal cord segmentation with topology constraints for variable fields of view.
Enlargement of cerebral ventricles as an early indicator of encephalomyelitis.
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.
A survey of advice on driving in neurological conditions amongst neurologists and neurosurgeons.
The Challenges, Advantages, and Future of Phenome-Wide Association Studies.
Paraoxonase 1 in neurological disorders.
Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis.
Pages
« first
‹ previous
…
627
628
629
630
631
632
633
634
635
…
next ›
last »